Dauerhafte URL dieser Seite: https://heibib.ub.uni-heidelberg.de/person/1155327845
Veelken, Kaya (Dr. med.)
Newest Titles
- Elotuzumab in combination with dose reduced IMiDs and dexamethasone for AL amyloidosis patients with relapsed/refractory plasma cell dyscrasia and advanced organ involvementArticle (Journal), Online Resource
- Graded organ response and progression criteria for kidney immunoglobulin light chain amyloidosisArticle (Journal), Online Resource
- Graded cardiac response criteria for patients with systemic light chain amyloidosisArticle (Journal), Online Resource
- Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research GroupArticle (Journal), Online Resource
- Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21Article (Journal), Editorial, Online Resource